Response to our Olympic press conference has been incredible! With the media surrounding Steve’s success with the C3-R procedure transforming his 20/500 vision to 20/20, hundreds of people suffering from similar ailments are contacting us in hopes of restoring their lost sight.
C3-R, cornea collagen crosslinking with riboflavin, is not taking center podium as the first line treatment for those diagnosed with keratoconus. Rather than waiting around for vision to slowly worsen, patients are doing their own research and quickly making the decision to undergo this non-invasive first line of defense treatment.
Patients are reporting improved quality of vision after the C3-R treatment in their current contact lenses or glasses. The reports of success with C3-R are exciting. Especially the studies showing that patients are avoiding the need for cornea transplant after C3R has stabilized the vision.
Tags: C3-R, Collagen crosslinking, Colleagen crosslinking, cornea transplant, Crosslinking, KC, Keratoconus, Steve Holcomb, Transepithelial Crosslinking